- Home
- SOHU vs MREO Comparison
SOHU vs MREO Comparison
Compare SOHU & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- MREO
- Stock Information
- Founded
- SOHU 1996
- MREO 2015
- Country
- SOHU China
- MREO United Kingdom
- Employees
- SOHU 4700
- MREO N/A
- Industry
- SOHU EDP Services
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- MREO Health Care
- Exchange
- SOHU Nasdaq
- MREO Nasdaq
- Market Cap
- SOHU 491.1M
- MREO 577.6M
- IPO Year
- SOHU 2000
- MREO N/A
- Fundamental
- Price
- SOHU $14.80
- MREO $4.38
- Analyst Decision
- SOHU
- MREO Strong Buy
- Analyst Count
- SOHU 0
- MREO 4
- Target Price
- SOHU N/A
- MREO $7.50
- AVG Volume (30 Days)
- SOHU 66.2K
- MREO 874.3K
- Earning Date
- SOHU 08-05-2024
- MREO 11-13-2024
- Dividend Yield
- SOHU N/A
- MREO N/A
- EPS Growth
- SOHU N/A
- MREO N/A
- EPS
- SOHU N/A
- MREO N/A
- Revenue
- SOHU $598,512,000.00
- MREO $1,000,000.00
- Revenue This Year
- SOHU N/A
- MREO $16.39
- Revenue Next Year
- SOHU $0.93
- MREO $9.44
- P/E Ratio
- SOHU N/A
- MREO N/A
- Revenue Growth
- SOHU N/A
- MREO N/A
- 52 Week Low
- SOHU $7.80
- MREO $1.07
- 52 Week High
- SOHU $16.34
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- SOHU 54.67
- MREO 47.85
- Support Level
- SOHU $14.91
- MREO $4.01
- Resistance Level
- SOHU $15.50
- MREO $4.72
- Average True Range (ATR)
- SOHU 0.35
- MREO 0.22
- MACD
- SOHU -0.04
- MREO -0.05
- Stochastic Oscillator
- SOHU 53.68
- MREO 32.95
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. The company is involved in the development, operation, and licensing of online games for PCs and mobile devices, which include massively multiplayer online role-playing games, casual games, and strategy games. In addition, it operates focus.cn, which provides online real estate information and services; and 17173.com website, which provides news, electronic forums, online videos, and other online game information services to game players, as well as offers mobile game distribution services. It generates maximum revenue from the Changyou segment.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).